PFIZER INC Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31)
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31) of -$13.00 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax · last filed 2013-05-10
- PFIZER INC other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2013-03-31 was -$13.00M, a 176.47% decline year-over-year.
- PFIZER INC other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2012-12-31 was -$21.00M.
- PFIZER INC other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2012-09-30 was -$9.00M, a 139.13% decline year-over-year.
- PFIZER INC other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2012-07-01 was $16.00M.
- PFIZER INC other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for fiscal 2012 was $3.00M, a 80.00% decline from fiscal 2011.
- PFIZER INC other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for fiscal 2011 was $15.00M.
- PFIZER INC other comprehensive income (loss), reclassification adjustment for sale of securities included in net income, before tax (deprecated 2013-01-31) for fiscal 2010 was -$141.00M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31) 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, before Tax (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | -$13.00M 10-Q · filed 2013-05-10 | -$34.00M derived: sum of 2 quarters · filed 2013-05-10 | -$43.00M derived: sum of 3 quarters · filed 2013-05-10 | -$27.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-12-31 | -$21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$30.00M derived: sum of 2 quarters · filed 2013-02-28 | -$14.00M derived: sum of 3 quarters · filed 2013-02-28 | $3.00M 10-K · filed 2013-02-28 |
| 2012-09-30 | -$9.00M 10-Q · filed 2012-11-09 | $7.00M derived: sum of 2 quarters · filed 2012-11-09 | $24.00M 10-Q · filed 2012-11-09 | $7.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-07-01 | $16.00M 10-Q · filed 2012-08-09 | $33.00M 10-Q · filed 2012-08-09 | $16.00M derived: sum of 3 quarters · filed 2013-05-10 | $39.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-04-01 | $17.00M 10-Q · filed 2013-05-10 | $0.00 derived: sum of 2 quarters · filed 2013-05-10 | $23.00M derived: sum of 3 quarters · filed 2013-05-10 | $22.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | -$17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $6.00M derived: sum of 2 quarters · filed 2013-02-28 | $5.00M derived: sum of 3 quarters · filed 2013-02-28 | $15.00M 10-K · filed 2013-02-28 |
| 2011-10-02 | $23.00M 10-Q · filed 2012-11-09 | $22.00M derived: sum of 2 quarters · filed 2012-11-09 | $32.00M 10-Q · filed 2012-11-09 | |
| 2011-07-03 | -$1.00M 10-Q · filed 2012-08-09 | $9.00M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | -$141.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |